Voyageur Pharmaceuticals (VYYRF) Stock Price, News & Analysis

Company Overview

Voyageur Pharmaceuticals, Inc. is a biopharmaceutical company specializing in advanced drug-delivery technologies and contract development services. The company focuses on formulating and optimizing therapeutic compounds to enhance stability, bioavailability and controlled-release properties. By leveraging proprietary polymer- and lipid-based delivery platforms, Voyageur aims to partner with pharmaceutical and biotechnology firms to address formulation challenges in high-value therapeutic areas, including oncology, endocrinology and central nervous system disorders.

The company’s core offerings include formulation development, analytical testing, preclinical evaluation and small-scale manufacturing support. Through these services, Voyageur helps clients advance candidate molecules from early-stage proof-of-concept to IND-enabling studies, de-risking programs and shortening development timelines. Its technical capabilities encompass nano-and micro-particle engineering, sterile injectable systems, oral controlled-release formulations and other specialized dosage forms designed to improve patient compliance and therapeutic outcomes.

Voyageur Pharmaceuticals is headquartered in the United States and serves a global customer base of emerging biotech firms and established pharmaceutical companies. The company’s collaborative approach combines internal R&D expertise with strategic external partnerships to tailor delivery solutions for novel and legacy drug candidates. Led by a management team with extensive experience in pharmaceutical development and regulatory affairs, Voyageur continues to expand its platform capabilities and position itself as a contract development organization of choice for challenging drug-delivery projects.

Key Stats

• Today's Range: $0.10 to $0.10
• 50-Day Range: $0.10 to $0.13
• 52-Week Range: $0.00 to $0.25
• Volume: 5,000 shs
• Average Volume: 44,647 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VYYRF Stock Analysis - Frequently Asked Questions

How have VYYRF shares performed this year?

Voyageur Pharmaceuticals' stock was trading at $0.0781 at the start of the year. Since then, VYYRF stock has increased by 21.6% and is now trading at $0.0950.

How do I buy shares of Voyageur Pharmaceuticals?

Shares of VYYRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:VYYRF
• CIK: N/A
• Web: www.voyageurminerals.ca
• Phone: (587) 779-6166
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A